๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Increasing drug resistance in human lung cancer cells by mutant-type p53 gene mediated by retrovirus

โœ Scribed by Zhenqiang Gao; Zhiping Gao; Xifu Liu; Tao Zhang

Publisher
Science in China Press (SCP)
Year
1997
Tongue
English
Weight
412 KB
Volume
40
Category
Article
ISSN
1674-7305

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Drug-resistant human bladder-cancer cell
Drug-resistant human bladder-cancer cells are more sensitive to adenovirus-mediated wild-type p53 gene therapy compared to drug-sensitive cells
โœ Toshiro Shirakawa; Ryohei Sasaki; Thomas A. Gardner; Chinghai Kao; Zhu-Jun Zhang ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 373 KB

We investigated the therapeutic potential and molecular mechanism of adenovirus-mediated wt p53 gene therapy for drug-resistant human bladder cancers. KK47, a human bladder-cancer cell line, along with the drug-resistant sublines KK47/DDP10, KK47/DDP20 (cisplatin-resistant) and KK47/ ADM (doxorubici

Tissue-specific growth suppression and c
Tissue-specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral-mediated transfer of the wild-type p53 gene
โœ G W Xu; Z T Sun; K Forrester; X W Wang; J Coursen; C C Harris ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 646 KB

HCC patients are generally resistant to chemotherapy, Selective expression of cytotoxic gene products in tuwhich, in some cases, may be the result of a loss of function mor cells is one of the goals of gene therapy for treating mutation in the p53 gene. cancer. We are developing such a strategy for

Identification of a novel breast-cancer-
Identification of a novel breast-cancer-anti-estrogen-resistance (BCAR2) locus by cell-fusion-mediated gene transfer in human breast-cancer cells
โœ Lambert C.J. Dorssers; Jos Veldscholte ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 177 KB ๐Ÿ‘ 2 views

Development of anti-estrogen resistance limits the benefit of endocrine therapy of breast cancer. The mechanistic basis for resistance to the anti-estrogen tamoxifen may involve (epi)genetic alterations within tumor cells. We have initiated a random search for genes allowing estrogen-dependent ZR-75